Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.49 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | F10 | P00742 | 1/20 | 0.39 |
| ▸ | F7 | P08709 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6137874 | 0.84 | F2 (0.54) | HPGDSCN5ASCN2AGPR52L3MBTL1 | |
| SCHEMBL6137843 | 0.82 | TDP1 (0.45) | SMN1; SMN2MAPK1KMT2ASIGMAR1F2 | |
| SCHEMBL6137934 | 0.77 | SCN5A (0.49) | SCN5ASCN2AKMT2AL3MBTL1SIGMAR1 | |
| SCHEMBL6003647 | 0.77 | LPAR1 (0.53) | HPGDSCN5ASCN2AKMT2AGPR52 | |
| SCHEMBL6138071 | 0.74 | MAPT (0.47) | HPGDSMN1; SMN2SCN5ASCN2AKMT2A | |
| SCHEMBL1744969 | 0.72 | NOS1 (0.52) | SMN1; SMN2KMT2A | |
| SCHEMBL2228231 | 0.72 | KMT2A (0.71) | HPGDSMN1; SMN2TSHRMAPK1KMT2A | |
| Hydrochloric Acid SCHEMBL7881498 | 0.72 | AR (0.50) | HPGDMAPK1ALDH1A1 | |
| SCHEMBL6869180 | 0.71 | KMT2A (0.47) | HPGDTSHRMAPK1KMT2AALDH1A1 | |
| SCHEMBL8582839 | 0.70 | HPGD (0.44) | HPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1032556-A4 | PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE | CAMBRIDGE NEUROSCIENCE INC (US) | 2005-02-02 | — | — | EP | disclosed |
| EP-1032556-A1 | PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE | CAMBRIDGE NEUROSCIENCE, INC. (US) | 2000-09-06 | — | — | EP | disclosed |
| WO-1999020599-A1 | PHARMACEUTICALLY ACTIVE COMPOUNDS AND METHODS OF USE | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1999-04-29 | — | — | WO | disclosed |